Abbott takes $622 million charge for marketing practices
This article was originally published in Clinica
Executive Summary
Abbott Laboratories expects to take a $622m charge in the second quarter of 2003 as a result of a settlement of a civil and criminal investigation of its marketing practices by the US government.